Product identification
Medicine name:
Kelevo 800 µg tablets for dogs
Active substance:
- Levothyroxine sodium
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levothyroxine sodium800.00/microgram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Aluminium - Aluminium blister each with 25 tablets. Cardboard box with 50 tablets
- Aluminium - Aluminium blister each with 10 tablets. Cardboard box with 100 tablets
- Aluminium - Aluminium blister each with 10 tablets. Cardboard box with 50 tablets.
- Aluminium - Aluminium blister each with 10 tablets. Cardboard box with 250 tablets
- Aluminium - Aluminium blister each with 25 tablets. Cardboard box with 250 tablets
- Aluminium - Aluminium blister each with 25 tablets. Cardboard box with 100 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- aniMedica GmbH
- aniMedica Herstellungs GmbH
- Industrial Veterinaria S.A.
- Lelypharma B.V.
Authorisation number:
- 73684/02-08-2021/K-0245103
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0349/003
Concerned member states:
-
Austria
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Slovenia
-
Spain
Documents
Combined File of all Documents
English (PDF)
Download Published on: 11/11/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 28/08/2025
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 28/08/2025